America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
AI is revolutionizing healthcare, finance, and more, say NVIDIA's Trivedi and Uniphore's Sachdev, showcasing efficiency and cost savings across sectors.